DIVISLAB:NSE
Divi's Laboratories Ltd
₹9,426.00
arrow_upward
+0.92%(+86.00) 1D
Oct 12, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DIVISLAB...
Open
₹9,346.00
High
₹9,431.50
Low
₹9,297.00
Mkt. cap
2.50T
Avg. vol.
506.19K
Volume
358.50K
Dividend
0.32%
Quarterly dividend
₹7.50
Ex-dividend date
Jul 24, 2026
P/E ratio
85.54
52-wk high
₹9,740.00
52-wk low
₹5,647.50
EPS
₹110.20
Shares outstanding
265.47M
No. of employees
12K
Open
₹9,346.00
High
₹9,431.50
Low
₹9,297.00
Mkt. cap
2.50T
Avg. vol.
506.19K
Volume
358.50K
Dividend
0.32%
Quarterly dividend
₹7.50
Ex-dividend date
Jul 24, 2026
P/E ratio
85.54
52-wk high
₹9,740.00
52-wk low
₹5,647.50
EPS
₹110.20
Shares outstanding
265.47M
No. of employees
12K
News stories
From web sources and news partners
Simply Wall Street
·
19 minutes ago
Why Does Space Exploration Technologies (SPCX) Need 15,000 More Satellites And Cape Launches?
The Motley Fool
·
11 minutes ago
Not Sandisk, Not Intel. This Stock Will Lead the S&P 500 Next Year
Yahoo Finance
·
4 hours ago
A handful of tech stocks are masking an ugly S&P 500 problem
The Detroit News
·
2 hours ago
Oil surge keeps S&P 500, Nasdaq in check before earnings; Salesforce lifts Dow
Profile
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization. Wikipedia
About Divi's Laboratories Ltd